Aquestive Therapeutics (AQST)
(Delayed Data from NSDQ)
$3.93 USD
+0.03 (0.77%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $3.92 -0.01 (-0.25%) 4:48 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Aquestive Therapeutics, Inc. [AQST]
Reports for Purchase
Showing records 121 - 140 ( 397 total )
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Early Xmas Gift on Hold; Libervant PDUFA Extended Indefinitely, AQST-109 Update
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Weekly Symphony Health Estimates for SYMPAZAN
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Libervant Approval Decision Imminent; 3Q21 Financials; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Weekly Symphony Health Estimates for SYMPAZAN™
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Q3: Focus Remains on Libervant Dec 23 PDUFA and Progression of AQST-109 Program
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Positive AQST-109 Phase 1 Data Released; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Race Against the Clock: AQST-109 Phase 1 PK Data Reveals Fast Time to Rescue
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Aquestive Therapeutics, Inc.
Industry: Medical - Drugs
Weekly Symphony Health Estimates for SYMPAZAN
Provider: WEDBUSH SECURITIES INC.
Analyst: Research Department